ALGERNON Trademark

Trademark Overview

On Tuesday, July 9, 2019, a trademark application was filed for ALGERNON with the United States Patent and Trademark Office. The USPTO has given the ALGERNON trademark a serial number of 88505722. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Friday, April 25, 2025. This trademark is owned by Breathtec Biomedical Inc.. The ALGERNON trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals for use in the treatment of kidney diseases, liver diseases, and inflammatory bowel diseases and pulmonary diseases namely coughs and lung cancer
algernon

General Information

Serial Number88505722
Word MarkALGERNON
Filing DateTuesday, July 9, 2019
Status730 - FIRST EXTENSION - GRANTED
Status DateFriday, April 25, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 3, 2024

Trademark Statements

Goods and ServicesPharmaceuticals for use in the treatment of kidney diseases, liver diseases, and inflammatory bowel diseases and pulmonary diseases namely coughs and lung cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, July 16, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameALGERNON PHARMACEUTICALS INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressVANCOUVER, BC V6C1G8
CA
Party NameALGERNON PHARMACEUTICALS INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressVANCOUVER, BC V6C 1G8
CA
Party NameBreathtec Biomedical Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressVancouver, BC V6C1G8
CA

Trademark Events

Event DateEvent Description
Wednesday, October 2, 2019PRIORITY ACTION WRITTEN
Friday, July 12, 2019NEW APPLICATION ENTERED
Tuesday, July 16, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, September 25, 2019ASSIGNED TO EXAMINER
Wednesday, October 2, 2019PRIORITY ACTION E-MAILED
Wednesday, October 2, 2019NOTIFICATION OF PRIORITY ACTION E-MAILED
Thursday, October 3, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, October 3, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, October 4, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 7, 2019SUSPENSION LETTER WRITTEN
Monday, October 7, 2019LETTER OF SUSPENSION E-MAILED
Monday, October 7, 2019NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, December 18, 2019AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, April 28, 2020ASSIGNED TO LIE
Wednesday, April 29, 2020SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Wednesday, April 29, 2020SUSPENSION INQUIRY WRITTEN
Wednesday, April 29, 2020INQUIRY TO SUSPENSION E-MAILED
Wednesday, April 29, 2020NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Friday, September 11, 2020TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Tuesday, September 15, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 15, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, September 21, 2020SUSPENSION LETTER WRITTEN
Monday, September 21, 2020LETTER OF SUSPENSION E-MAILED
Monday, September 21, 2020NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, July 22, 2021SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Monday, August 2, 2021SUSPENSION INQUIRY WRITTEN
Monday, August 2, 2021INQUIRY TO SUSPENSION E-MAILED
Monday, August 2, 2021NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Wednesday, August 25, 2021TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, September 1, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 1, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 2, 2021SUSPENSION LETTER WRITTEN
Thursday, September 2, 2021LETTER OF SUSPENSION E-MAILED
Thursday, September 2, 2021NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, May 2, 2022SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Friday, June 3, 2022SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Friday, June 24, 2022SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Wednesday, July 20, 2022SUSPENSION INQUIRY WRITTEN
Wednesday, July 20, 2022INQUIRY TO SUSPENSION E-MAILED
Wednesday, July 20, 2022NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Tuesday, July 26, 2022TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, July 28, 2022ASSIGNED TO LIE
Thursday, July 28, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 28, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, August 4, 2022SUSPENSION LETTER WRITTEN
Thursday, August 4, 2022LETTER OF SUSPENSION E-MAILED
Thursday, August 4, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, March 6, 2023SUSPENSION INQUIRY WRITTEN
Monday, March 6, 2023INQUIRY TO SUSPENSION E-MAILED
Monday, March 6, 2023NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Wednesday, May 31, 2023TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, June 1, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, June 1, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, June 2, 2023SUSPENSION LETTER WRITTEN
Friday, June 2, 2023LETTER OF SUSPENSION E-MAILED
Friday, June 2, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, January 10, 2024SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Tuesday, January 23, 2024SUSPENSION INQUIRY WRITTEN
Tuesday, January 23, 2024INQUIRY TO SUSPENSION E-MAILED
Tuesday, January 23, 2024NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Tuesday, March 26, 2024TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, March 27, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 27, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 3, 2024ASSIGNED TO EXAMINER
Monday, July 29, 2024EXAMINER'S AMENDMENT ENTERED
Monday, April 29, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, April 29, 2024FINAL REFUSAL WRITTEN
Monday, April 29, 2024FINAL REFUSAL E-MAILED
Monday, July 29, 2024EXAMINERS AMENDMENT E-MAILED
Monday, July 29, 2024EXAMINERS AMENDMENT -WRITTEN
Monday, July 29, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, July 29, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 14, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 3, 2024PUBLISHED FOR OPPOSITION
Friday, April 25, 2025SOU TEAS EXTENSION RECEIVED
Wednesday, October 1, 2025TEAS DELETE 1(B) BASIS RECEIVED
Saturday, April 26, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 3, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 29, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, April 25, 2025SOU EXTENSION 1 FILED
Friday, April 25, 2025SOU EXTENSION 1 GRANTED

Related Keywords

algernon diseases coughs namely lung cancer pulmonary inflammatory treatment kidney liver